About Enable Injections
Enable Injections is a company based in Cincinnati (United States) founded in 2010 by Mike Hooven.. Enable Injections has raised $334.27 million across 11 funding rounds from investors including Cincinnati Children’s, Grosvenor Capital Management and Sanofi. The company has 185 employees as of December 31, 2023. Enable Injections offers products and services including enFuse Wearable, enFuse Transfer Systems, enFuse Smart Technology, and Empaveli. Enable Injections operates in a competitive market with competitors including Micron Biomedical, Zosano Pharma, Raphas, SkinJect and STM, among others.
- Headquarter Cincinnati, United States
- Employees 185 as on 31 Dec, 2023
- Founders Mike Hooven
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Enable Injections
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$334.27 M (USD)
in 11 rounds
-
Latest Funding Round
$30 M (USD), Series C
Jan 06, 2026
-
Investors
Cincinnati Children’s
& 11 more
-
Employee Count
185
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Enable Injections
Enable Injections offers a comprehensive portfolio of products and services, including enFuse Wearable, enFuse Transfer Systems, enFuse Smart Technology, and Empaveli. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Wearable device for hands-free subcutaneous medication delivery.
Systems for transferring medications in wearable formats.
Intelligent features for monitoring and administering drugs.
Wearable injector for specific drug therapies.
Unlock access to complete
Unlock access to complete
Funding Insights of Enable Injections
Enable Injections has successfully raised a total of $334.27M across 11 strategic funding rounds. The most recent funding activity was a Series C round of $30 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Series C — $30.0M
- First Round First Round
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2026 | Amount | Series C - Enable Injections | Valuation |
investors |
|
| Jan, 2022 | Amount | Series C - Enable Injections | Valuation | Magnetar | |
| Sep, 2020 | Amount | Debt – Conventional - Enable Injections | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Enable Injections
Enable Injections has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Cincinnati Children’s, Grosvenor Capital Management and Sanofi. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Magnetar Capital is engaged in alternative asset management.
|
Founded Year | Domain | Location | |
|
Private fund focused on debt and equity investments in real estate and multiple sectors
|
Founded Year | Domain | Location | |
|
Early-stage sector-agnostic VC firm investing in geographies such as the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Enable Injections
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Enable Injections
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Enable Injections Comparisons
Competitors of Enable Injections
Enable Injections operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Micron Biomedical, Zosano Pharma, Raphas, SkinJect and STM, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Microneedle patches are developed for vaccine and drug delivery.
|
|
| domain | founded_year | HQ Location |
Develops innovative transdermal drug delivery technologies for various therapeutic applications.
|
|
| domain | founded_year | HQ Location |
Microneedle technology is developed for cosmetics and medical applications.
|
|
| domain | founded_year | HQ Location |
Dissolvable microneedle patches for non-melanoma skin cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Transdermal patches for painless vaccine delivery via microneedles are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Enable Injections
Frequently Asked Questions about Enable Injections
When was Enable Injections founded?
Enable Injections was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Where is Enable Injections located?
Enable Injections is headquartered in Cincinnati, United States. It is registered at Cincinnati, Ohio, United States.
Who is the current CEO of Enable Injections?
Mike Hooven is the current CEO of Enable Injections. They have also founded this company.
Is Enable Injections a funded company?
Enable Injections is a funded company, having raised a total of $334.27M across 11 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $25M, raised on Apr 05, 2011.
How many employees does Enable Injections have?
As of Dec 31, 2023, the latest employee count at Enable Injections is 185.
What does Enable Injections do?
Provider of a wearable drug delivery solution. The companys drug delivery device include enFuse for injectable therapies which enables a range of flexible delivery options for patients and healthcare providers, including a range of viscosities, volumes, delivery times, and sites for administration.
Who are the top competitors of Enable Injections?
Enable Injections's top competitors include Micron Biomedical, SkinJect and Raphas.
What products or services does Enable Injections offer?
Enable Injections offers enFuse Wearable, enFuse Transfer Systems, enFuse Smart Technology, and Empaveli.
Who are Enable Injections's investors?
Enable Injections has 12 investors. Key investors include Cincinnati Children’s, Grosvenor Capital Management, Sanofi, Barings, and Oxford Finance.